β-Fibrinogen gene -455 G/A polymorphism and fibrinogen levels: Risk factors for coronary artery disease in subjects with NIDDM

Diabetes Care

Volumn 19, Issue 11, 1996, Pages 1265-1268

  Carter, Angela M ^a,b   Mansfield, Michael W ^a   Stickland, Max H ^a   Grant, Peter J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN B BETA CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0029955798     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.11.1265     Document Type: Article

References (35)

1. Kannal WB, McGee DL: Diabetes and cardiovascular disease, the Framingham Study. JAMA 241:2035-2038, 1979
2. Reaven GM: Role of insulin resistance in human disease. Diabetes, 37:1595-1607, 1988
3. Juhan-Vague I, Alessi MC: Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost 70:138-143, 1993
4. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor-1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 34:457-462, 1991
5. Heywood DM, Mansfield MW, Grant PJ: Factor VII gene polymorphisms, Factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemost 75:401-406, 1996
6. Ostermann H, van de Loo J: Factors of the haemostatic system in diabetic patients. Haemostasia 16:386-390, 1986
7. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet ii:533-537, 1986
8. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo JC: Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arter Thromb 14:54-59, 1994
9. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectons Study Group. N Engl J Med 332:635-641, 1995
10. Wilhelmsen L, Svårdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505, 1984
11. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183-1186, 1987
12. Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E: Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87:1915-1920, 1993
13. Henschen A, Lottspeich F, Kehl M, Southan C: Covalent structure of fibrinogen. Ann NY Acad Sci 408:13-27, 1983
14. Meade TW, Chakrabarti R, Haines AP, North WR, Stirling Y: Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ 1:153-156, 1979
15. Hamsten A, Iselius L, De Faire U, Blomback M: Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet ii:988-990, 1987
16. Friedlander Y, Elkana Y, Sinnreich R, Kark JD: Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study. Am J Hum Genet 56:1194-1206, 1995
17. Meade TW, Imeson J, Stirling Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet ii:986-988, 1987
18. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW: Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet ii:1452-1455, 1987
19. -455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vacs Biol 15:96-104, 1995
20. Green F, Hamsten A, Blomback M, Humphries S: The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 70:915-920, 1993
21. Connor JM, Fowkes FG, Wood J, Smith FB, Donnan PT, Lowe GD: Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 29:480-482, 1992
22. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE: Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 65:487-490, 1991
23. Mansfield MW, Stickland MH, Grant PJ: Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 74:1032-1034, 1995
24. Clauss A: Gerinnungsphysiologishce Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237-246, 1957
25. Mansfield MW, Heywood DM, Grant PJ: Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16:160-164, 1996
26. Mansfield MW, Stickland MH, Carter AM, Grant PJ: Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy. Thromb Haemost 71:731-736, 1994
27. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F: Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arter Thromb 13:886-891, 1993
28. de Maat MPM, de Knijff P, Green FR, Thomas AE, Jespersen J, Kluft C: Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. Arterioscler Thromb Vasc Biol 15:856-860, 1995
29. Thomas A, Lamlum H, Humphries S, Green F: Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and Bcll (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum Mutat 3:79-81, 1994
30. Lane A, Humphries SE, Green FR: Effect on transcription of two common genetic polymorphisms adjacent to the promoter region of the β-fibrinogen gene (Abstract). Thromb Haemost 69:1517, 1993
31. Baumann RE, Henschen AH: Genetic variation in human β fibrinogen gene promoter influences formation of a specific DNA-protein complex with the interleukin 6 response element (Abstract). Thromb Haemost 69:961, 1993
32. Green F, Lane A, Humphries S: The effect of genetic variation in the β-fibrinogen 5′-flanking region on nuclear protein binding, transcriptional activity and plasma fibrinogen level (Abstract). Thromb Haemost 73:1224, 1995
33. Snowden C, Houlston R, Laker MF, Kesteven P, Alberti KG, Humphries SE: Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics. Dis Markers 10:159-167, 1992
34. Fowkes FG, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GD: Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 339:693-696, 1992
35. Baumann RE, Henschen AH: Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet 94:165-170, 1994